Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Drugs of Abuse (DOA) Testing Market Growth Potential: How Will Market Size Change Through 2030?

The market for drugs of abuse testing has experienced robust expansion lately, projecting a rise from $7.97 billion in 2025 to $8.68 billion in 2026, fueled by a compound annual growth rate (CAGR) of 9.0%. This historical growth trajectory has been propelled by factors such as stringent workplace safety rules, the pervasive issue of substance abuse, requirements for screening within the criminal justice system, the increasing use of immunoassay testing methods, and the enhancement of laboratory facilities.

The global market for drug of abuse (doa) testing is poised for substantial expansion over the upcoming years, projecting a rise to $12.17 billion by the year 2030, fueled by an 8.8% compound annual growth rate (CAGR). This anticipated surge is largely driven by an increasing need for remote workplace testing solutions, the growing preference for oral fluid testing methodologies, enhanced integration of real-time data analytics, a broader scope of regulatory enforcement, and the proliferation of public health monitoring initiatives. Key developments anticipated during this forecast period encompass the escalating implementation of workplace drug screening protocols, a heightened demand for swift point-of-care diagnostic tools, the wider availability of multi-panel drug testing kits, increased reliance on laboratory confirmation for testing accuracy, and the seamless integration of digital reporting and comprehensive data management systems.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9381&type=smp

Drugs of Abuse (DOA) Testing Market Demand Drivers Creating New Revenue Opportunities

A heightened need for addiction treatment is anticipated to be a primary catalyst for the expansion of the drugs of abuse (DOA) testing market. Drug abuse, often termed substance abuse, involves consuming substances in amounts detrimental to individuals or society. Drug testing serves as a crucial tool for detecting substances not naturally present in the body, typically involving an initial screening followed by a confirmatory analysis to verify the presence of specific compounds. This escalating requirement for addiction treatment directly fuels the growth of the DOA testing sector. As an illustration, data from GOV. UK in December 2023 indicated that drug and alcohol services were utilized by 290,635 adults in the UK between April 2022 and March 2023, a marginal rise from the preceding year’s figure of 289,215. Furthermore, treatment admissions saw an increase to 137,749, continuing an upward trend from 130,490 and 133,704 in the two years prior, thus underscoring how the growing demand for substance abuse treatment is propelling the drugs of abuse (DOA) testing market.

Drugs of Abuse (DOA) Testing Market Segmentation: How Is The Market Structured Across Key Categories?

The drugs of abuse (doa) testing market covered in this report is segmented –

1) By Product And Service: Analyzers, Rapid Testing Devices, Consumables, Laboratory Services

2) By Sample Type: Urine, Hair, Oral Fluid, Breath

3) By Application: Pain Management, Criminal Justice, Workplace Screening

4) By End User: Hospitals, Diagnostic Laboratories, Forensic Laboratories, Other End Users

Subsegments:

1) By Analyzers: Immunoassay Analyzers, Chromatography-Based Analyzers, Mass Spectrometry Systems

2) By Rapid Testing Devices: Urine Test Kits, Saliva Test Kits, Hair Test Kits

3) By Consumables: Test Strips, Reagents, Sample Collection Devices

4) By Laboratory Services: Toxicology Testing, Confirmation Testing, Screening Services

Drugs of Abuse (DOA) Testing Market Trends Driving Strategic Industry Expansion

Leading players within the drugs of abuse (DOA) testing sector are prioritizing the creation of cutting-edge solutions, including software-as-a-service (SaaS) models, with the aim of boosting testing effectiveness, refining data handling capabilities, and solidifying their market standing. A SaaS platform represents a cloud-hosted application managed by an external entity, accessible through online connectivity, which empowers users to optimize operational processes, interrogate extensive information archives, and derive practical knowledge without requiring onsite software installation. Illustratively, in December 2023, Merck KGaA, a prominent science and technology firm headquartered in the United States, introduced Addison, a sophisticated software solution for drug discovery. This platform synergizes computer-aided design techniques, machine learning algorithms, and generative artificial intelligence to expedite the creation of new medications. Addison facilitates the generation of synthesis recommendations for theoretical molecules, bridges the gap between digital molecular design and real-world production feasibility, and unearths concealed patterns within massive data repositories, thereby enhancing the probability of bringing successful novel treatments to those in need.

Drugs of Abuse (DOA) Testing Market Competitive Landscape And Leading Companies

Major companies operating in the drugs of abuse (doa) testing market are Siemens AG, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Inc., bioMérieux Inc., Dragerwerk AG & Co. KGaA, Aegis Sciences Corporation, NMS Labs, Clinical Reference Laboratory Inc., Cordant Health Solutions, Millennium Health, ACM Global Laboratories, Psychemedics Corporation, Alfa Scientific Designs Inc., Alere Toxicology Services, Omega Laboratories Inc., BioTek Laboratories, Premier Biotech Inc., Dominion Diagnostics LLC, Randox Toxicology Ltd., Cansford Laboratories Ltd., United States Drug Testing Laboratories Inc., American Bio Medica Corporation, Confirm BioSciences, Immunalysis Corporation, Medtox Diagnostics Inc., Forensic Fluids Laboratories

Access The Complete Drugs of Abuse (DOA) Testing Market Report:

https://www.thebusinessresearchcompany.com/report/drugs-of-abuse-doa-testing-global-market-report

Drugs of Abuse (DOA) Testing Market Global Footprint: Which Region Holds Market Leadership?

North Americawas the largest region in the drugs of abuse (DOA) testing market in 2025. Asia-Pacificis expected to be the fastest-growing region in the global drugs of abuse (DOA) testing market report during the forecast period. The regions covered in the drugs of abuse (doa) testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model